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Abstract- This paper addresses the topic of anticipating likely 
development paths for a particular “New and Emerging Science 
& Technology” (NES&T).  Characteristics of NES&T -- 
technological uncertainty and contextual dynamics -- pose 
challenges for technology management and forecasting practices.  
Researchers, technologists, R&D managers, staff in funding 
agencies and policy makers “need to know” future prospects.  
This requires better ways to capture NES&T development 
patterns, within their socio-economic context, as well as likely 
innovation opportunities.  A new technology forecasting 
framework for NES&Ts is presented, supported by a case study 




    “Analysis of emerging technologies” has been of interest 
for many years.  Recently, “New and Emerging Science & 
Technologies” (“NES&Ts”) have drawn the attention of 
Future-oriented Technology Analyses (“FTA”) researchers 
because of their uncertainty and dynamic characteristics [1]. 
NES&Ts challenge trusted FTA approaches, like technology 
roadmapping [2]. As a result, it’s an intriguing methodological 
challenge to decide what data and methods can yield effective 
future projections for NES&Ts.   
    This paper develops a conceptual framework to depict and 
forecast NES&Ts.  It is organized in four sections.  Key 
concepts and development status are discussed in Section 1.  
In Section 2, we set up a systematic technology forecasting 
approach framework for NES&Ts on the basis of traditional 
and new FTA methods.  We then apply these approaches to 
nano-enhanced biosensors as a case study in Section 3.  At last, 
a discussion of advantages and disadvantages of our proposed 
approach gained from the case study constitutes Section 4. 
 
II. CHALLENGES IN FORECASTING NEW AND EMERGING 
SCIENCE & TECHNOLOGIES 
 
    In recent decades, FTA has come forth to enrich our 
understanding of technological innovation within societal 
contexts, under highly dynamic conditions [3] (see also 
http://forera.jrc.ec.europa.eu/fta_2008/intro.html).  FTA may 
combine “aims” (normative aspects) concerning particular 
emerging technologies and “action” dimensions, such as 
analytical processes that better address technological 
uncertainties, risks, and opportunities. FTA can serve a wide 
range of potential users, from corporate managers to national 
policy makers.    
The FTA initiative blends many forms of analyzing future 
technology and its consequences -- for example, technology 
intelligence, forecasting, roadmapping, assessment, and 
foresight.  Using these approaches, FTA analysts can inform 
technology management, as well as science and research 
policy [4]. However, NES&Ts pose new challenges for 
effective FTA. 
Recently those engaged in FTA are beginning to distinguish 
science and technology development situations that warrant 
differentiated analytical strategies.  Technology forecasting 
for long-established developments, with dominant platforms 
(e.g., silicon-based information technologies) and 
incrementally changing applications are more amenable to 
trend analyses and growth modeling than are newly advancing 
scientific research areas with no applications yet (e.g., many 
nano and bio technologies).  Given their less predictable 
technical bases and complex societal contexts (development 
environment), it is very hard to anticipate the developmental 
paths that such technologies will follow.  This requires new 
ways of technology forecasting that capture development 
patterns, interactions with the societal environment, and 
forecasting of likely future innovations for a given NES&T.  
 We distinguish four aspects of NES&Ts that bear 
importantly on how to do FTA.  Posing these as the driving 
questions: 
(1) How best to understand the NES&T development 
situation? Many existing FTA approaches focus on exploring 
future possibilities, neglecting to make sure that we 
understand key “forces and factors” of the present situation.  
(2) How to convert knowledge of the present situation into 
the key technology management and forecasting issues to be 
addressed? From the viewpoint of the technology forecasting 
process, the starting point is really the end point---what 
information needs prompt this analysis and what questions
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need be resolved?  Moreover, what are the empirical 
indicators that can be generated by our FTA actions to help 
answer those questions?  
(3) How to adopt or adapt existing FTA methods to generate 
those indicators? The available data vary greatly for different 
NES&Ts. 
(4) How to present analytical results to aid management of 
the NES&T development – to enhance the opportunities and 
decrease the risks? 
NES&Ts pose special challenges as a function of many 
factors – factors that we are just now exploring, including: 
(a) How regular is the R&D process? 
Consider as one extreme the case of silicon-based 
microelectronics where the technology has advanced quite 
regularly for half a century.  At the other extreme are areas 
where breakthrough-based research advances spur “new” 
science and technology (e.g., contrast genetics before and after 
Polymerase Chain Reaction (PCR) enabled “instant” provision 
of unlimited DNA copies cheaply). 
(b) What applications are in place? 
NES&T maturity ranges from high (e.g., modification of 
properties of well-developed applications and markets) to low 
(e.g., at the stage of fundamental research for which potential 
applications are barely sketched out).  
These special considerations add to the inherent uncertainty 
of all FTA endeavors. 
 
III. THE NES&T TECHNOLOGY FORECASTING FRAMEWORK 
 
How can we best pursue FTA for NES&Ts?  We especially 
value “early stage” insights on likely development pathways 
as those provide the greatest leverage for wisely investing 
R&D resources.  Such early stage findings also enable real 
time technology assessment – i.e., engaging researchers and 
stakeholders in consideration of potential undesirable effects 
of applications in advance.  However, it’s really a challenge to 
investigate future innovation prospects from limited 
information available for a technology at an early stage of 
development.  Here, we approach the NES&T development 
situation from two angles (Fig. 1).  One is to characterize the 
status of the technology itself (“Characterize the Technology’s 
Nature & Maturation”); the other one [“Technology Delivery 
System (“TDS”) Modeling”] addresses the system.  The TDS 
approach distinguishes factors involved in taking a new 
technical capability to market from the contextual forces and 
factors affecting such technological innovation.      
There are different ways to characterize technology 
development stages.  For example, Technology Readiness 
Level (“TRL”) is a measure which is used by some United 
States government agencies and many of the world's major 
companies (and agencies) to assess the maturity of evolving 
technologies [5]. Here, we divide NES&Ts into two types 
according to the status of their applications: 1) emerging 
technologies with no applications at present; and 2) emerging 
technologies with few applications in the market.  The first 
type is likely to show as research with minimal focus on 
applications – i.e., mainly fundamental, not applied, research.  
The second type includes R&D that begins to note 
applications that may not be well defined yet and others with 
applications that are well developed, but amenable to notable 
enhancement.  How one forecasts likely developmental 
pathways will vary depending on the current stage and, 
consequently, the available information. 
Besides understanding a technology’s maturational stage, 
we want to know the contextual dynamics that could affect its 
potential innovation pathways.  As we known, technology and 
society are interrelated, and both are changing rapidly.  
Changes in technology feed upon themselves, producing a 
stock of concepts that may be refined, developed, and used as 
the basis for further change.  The development and 
dissemination of technology creates forces that can cause 
change in every aspect of society.  On the other hand, changes 
in society produce conditions that influence technological 
change.  We must understand these interrelationships to 
forecast and manage technology effectively [6].  Here, we take 
two perspectives to model this complex TDS to help realize 
the linkages along the “stream” from R&D toward commercial 
(or other) innovation [7].  “Push-to-Pull Enterprise Analyses” 
are used to identify the key players and their requirements to 
make prospective technological innovation occur.  
“Contextual Forces & Factors Analyses” seek to uncover 
factors that will drive innovation in particular ways, including 
any barriers that could hinder particular developments.   
Understanding the NES&T development situation (Stage 1 
of Fig. 1) provides a general sense of the key actors, interests, 
and potential innovations.  That is a valued result in its own 
right.  Such understanding should also help the analysts 
specify the key technology management issues. TABLE I 
offers a reasonable set of such issues from which to pick.  It 
must be pointed out that these issues can vary widely, 
depending on the technology itself, its particular contextual 
situation, and the particular interests of the intended users of 
the FTA [8].   
 
TABLE I 
  TECHNOLOGY MANAGEMENT ISSUES AND CONCERNS 
 
A. R&D portfolio selection 
B. R&D project initiation 
C. Engineering project initiation 
D. New product development 
E. New market development 
F. Mergers 
G. Acquisitions of intellectual property (“IP”) 
H. Exploiting one’s own intellectual assets 
I. Collaboration in technology development 
J. Identifying and assessing competing organizations 
K. Tracking and forecasting emerging or breakthrough 
technologies 
(opportunities & threats) 
L. Strategic technology planning 
M. Technology roadmapping 
Source: Tech Mining [8] 
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Fig.1. Future-oriented technology analyses for a new and emerging science and technology 
  
We suggest further amplification of the objectives of the 
FTA endeavor.  Stage 2 of Fig. 1 orients us toward particular 
“innovation indicators” – i.e., empirical and expert-based 
intelligence concerning the status and prospects of the NES&T 
under study.  Porter and Cunningham [8] list 39 tech mining 
questions and more than 200 indicators based on the 13 
technology management issues (TABLE I).  These are just 
suggestive; the technology analysts need to work with the 
intended study users to determine what information, in what 
form, would be most valuable in managing the NES&T in 
question.  Specifying particular target innovation indicators 
can help align FTA data selection and analytical efforts to 
assure that the effort is well focused. 
When the indicators are spelled out, we are ready to pursue 
detailed profiling work – i.e., Stage 3 of Fig. 1 – “Generate 
Indicators.”   Because of the limited life of most NES&Ts, we 
tend to focus on the front end of the technological innovation 
chain.  Stage 3 (Fig. 1) points us toward three facets:  R&D 
Profiling, Connecting R&D to possible Applications, and 
Profiling Commercialization Opportunities.  
There are many analytical tools to help profile R&D, 
including bibliometric analyses, social network analyses, and 
trend analyses.  We can adopt or adapt them to facilitate our 
study as a function of the NES&T developmental situation 
(and available information) and the desired innovation 
indicators.   
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 We have devised “S&T-Function-Application Cross-
Charting” to bridge the gap between R&D and Applications.  
This is vital to understand how particular technologies might 
link to potential applications.  In our nanobiosensors case, we 
began with very fuzzy notions that nanotechnology (“nano”) 
could contribute to biosensors.  After analyzing sets of R&D 
article abstracts and interacting with nanobiosensor 
researchers, we found it surprisingly helpful to systematically 
array the attributes of the technology (here, the features that 
nano offers) in terms of functional advantages, and, in turn, 
how those functions could translate into enhanced applications.   
We are still exploring how best to do cross-charting.  In this 
study and in companion analyses of nano-enhanced solar cells 
[9], we have found value in: 
(1) Subdividing the technical elements (e.g., distinguishing 
among various nano materials); 
(2) Engaging those knowledgeable about the technology in 
specifying the set of important, and distinctive, functions (i.e., 
what is important); 
(3)Exploring which functions pertain to particular 
applications (in some cases requiring partitioning functions 
and/or application sets); 
(4) Considering links between applications and commercial 
opportunities (users, sectors, etc.). 
To date our efforts have been qualitative in nature, albeit 
drawing upon leads provided by R&D and contextual 
literature and patent compilations. 
Investigating indications of cooperation between research 
organizations and companies is another useful way to capture 
early signals of commercialization intents.   Tabulating “who” 
(e.g., active industry players) and “what” (e.g., topics being 
emphasized) information can constitute useful innovation 
indicators.  Results should be well-presented with 
visualizations & interpretation to generate the “NES&T 
Intelligence Report.”   Well done, this should provide valuable 
information for technology managers and/or policy-makers.  
In Stage 4, we seek to take advantage of these analyses to 
give insights into strategic technology planning.  We want to 
map alternative innovation pathways.   This points us to 
demonstrate a plausible variety of paths by which the NES&T 
can contribute to innovations – i.e., new or improved products, 
services, or systems.  Such multipath mapping [2] can help 
articulate alternative futures.  Pathways can be structured in 
terms of prospective innovation chains (i.e., first generation 
products beget second generation, and so forth). Importantly, 
we want to identify alternative commercialization paradigms 
and their likelihoods.  Robinson and Propp [10] nicely 
counterpose a common platform “lab on a chip” innovation 
path versus highly specific, independent developmental 
options.   
Furthermore, we should assess potential NES&T impacts 
(desirable and not) of such alternative innovation pathways, to 
inform early developmental choices. 




IV. CASE STUDY: NANO-ENHANCED BIOSENSORS 
 
A.  Situational Understanding 
Nowadays, nanotechnology is playing an increasingly 
important role in the development of sensors.  Biosensors 
represent an especially exciting opportunity for high-impact 
applications benefiting from nano attributes.  Reviewing 
recent studies, we find a steep increase in the literature on 
nanobiosensors [11].   
In this case we focus on the interesting situation of 1) novel 
scientifically based enhancements of 2) an emerging 
technology, with 3) some existing applications.  “Nano-
enhanced biosensors” is our NES&T.  It is also of inherent 
interest for its highly multidisciplinary R&D and wide range 
of potentially important applications.   
TDS modeling seeks to identify what it will take to 
“deliver” NES&T applications to market – in this case, for 
nanobiosensors.  It involves multiple perspectives, including 
profiling R&D patterns, institutional involvements, major 
actors, and key markets.  To anticipate the development 
pathways for nanobiosensors, it is also essential to identify 
interactions among players and to explore potential supports 
and barriers in the environment.   This information could aid 
policy makers who wish to foster effective development.  In 
order to capture more detailed information and characteristics 
of nanomaterial-enhanced biosensor technology, we focus on 
the contextual environment in one of the top nanobiosensor 
research countries--USA [12].   
Fig. 2 characterizes a sociotechnical system composed of 
institutions directly or indirectly involved in developing 
nanomaterial-enhanced biosensor technology.  At the societal 
level, we categorize four key players: governments, R&D 
groups, manufacturers, and users.  We begin by thinking in 
terms of what will it take to translate particular nanoscience 
discoveries into bonafide innovations (i.e., products, processes, 
or services with significant commercial or other uses)?  In Fig. 
1, this was noted as “push-to-pull enterprise analyses.”  That 
alludes to the observation that sometimes (most times 
probably) NES&T interest derives from excitement emanating 
from a research discovery – the “push.”  Other times, interest 
is driven by an expressed need – “pull.” 
Government entities may address the social, political, and 
economic aspects of this new technology.  For the R&D 
funding role, we note two levels: Federal agencies provide the 
major share of support – such as the National Science 
Foundation (NSF); Environmental Protection Agency (EPA); 
Department of Energy (DOE); and National Institutes of 
Health (NIH).  State agencies also contribute to R&D support 
with relatively smaller shares (e.g., constructing new nano 
research facilities at universities, including Georgia Tech).  
Since nanobiosensor applications relate strongly to food and 
healthcare markets, relevant agencies are involved in 
regulating product development, like CDC (Centers for 
Disease Control and Prevention), USDA  U.S. Department of 
Agriculture), and, especially, FDA (Food and Drug 
Administration). 
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Fig.2. Nano-enhanced biosensor TDS for the USA 
 
“Nano” research is highly multidisciplinary [13], and the 
nanomaterial-enhanced biosensors R&D groups really present 
a highly multidisciplinary research picture, reflecting 
integration of material sciences, molecular engineering, 
chemistry, biotechnology, and electrical engineering.  In 
addition to the academic and non-profit/governmental research 
effort, some of the major biosensor companies are engaged in 
R&D programs [12].  
The Manufacturers for nano-enhanced biosensors in the US 
can be grouped into three types: Specialized manufacturer, 
start-up & small manufacturers, and large, multinational 
companies.  In the early stage of commercialization, the start-
up companies are playing important roles in nanobiosensor 
development, and most of them are funded by venture capital 
and university spin-offs.  A remarkable characteristic for these 
nano-enhanced biosensors manufacturers is strong cooperation 
with universities. 
Biosensors have been developed for more than a half-
century, but only in the last decade have commercial 
applications based on the new technologies become 
significantly available [14].  Until today, few biosensors based 
on nanomaterials are at work in commercial applications.  
Meanwhile, the emerging markets for biosensor technologies 
are shaping up in three dominant segments: healthcare, 
environment, and agriculture & food, with the healthcare 
markets overshadowing the others. Nanobiosensors will also 
likely be involved in other potential markets as well – e.g., in 
the field of homeland security and defense. 
 
B. Determining FTA Indicators 
Based on the nano-enhanced biosensors development 
situation analysis, we identify our case study’s Key 
Management of Technology (“MOT”) Issues (TABLE I) as:  
I.  Collaboration in technology development 
K. Tracking and forecasting emerging or breakthrough 
technologies (opportunities & threats) 
We accordingly come up with target MOT questions to 
address: 
• What are the key nanotechnologies/nanomaterials?  
• What are key technologies’ competing functions? 
• Which countries are the top ones for this research?  
• Which organizations are the top ones for this research?  
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• What are those organizations’ main academic and 
industry connections?  
• What sub-topics are the top players emphasizing? 
• What are the most promising opportunities for future 
commercialization? 
Next, we should specify innovation indicators to address 
these MOT questions.  Because nano-enhanced biosensors 
would enhance existing biosensor applications, it’s very 
important to identify their commercialization opportunities at 
this stage.  In this way, we should focus more on 
commercialization aspects, especially the connection between 
R&D and applications. Therefore, the main indicators in this 
case study may include:  
• Locate nanobiosensor research on the map of science 
• Map collaborations, looking for pointers toward potential 
commercial development 
• Compare national R&D efforts, as possible leading 
indicators of commercialization strengths 
• Matrix leading companies with topical research and 
patenting emphases 
• Cross-chart nanomaterials to functions to potential 
applications 
 
C.  Indicator Generation 
We now pursue the approach sketched in Fig. 1.  The main 
dataset serving in this case study comes from global 
nanotechnology research publications for the time period 2001 
through 2008(part year) extracted from the Science Citation 
Index (“SCI”), from which we have extracted 1400 records 
pertaining to nano-enhanced biosensors.  The detailed dataset 
building process is described elsewhere [12].  
 
Exploring R&D Multidisciplinary Aspects of This Research 
In this paper, we apply science overlay mapping to locate 
nanobiosensor R&D among the disciplines [15].  This 
approach uses the Subject Categories that Web of Science 
assigns to journals.  So, for a set of publications indexed by 
Web of Science (in this case, by SCI, which is part of Web of 
Science), we locate that research by the journals in which it 
appears.  Fig. 3 overlays nanobiosensor research over a base 
map reflecting the 175 Subject Categories shown by the 
background intersecting arcs.  The Subject Categories are 
grouped into “macro-disciplines” using Principal Components 
Analysis based on the degree of co-citation of the Subject 
Categories in a large sample of articles indexed by Web of 
Science [16].  Those macro-disciplines become the labels in 
the figure.  The nanobiosensor research concentrations appear 
as nodes in the map, with larger nodes reflecting greater 
numbers of publications. 
Fig. 3 illustrates that global nanobiosensor research involves 
a very extensive range of research fields. It is concentrated in 
the Materials Science and Chemistry macro-disciplines, also 
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Fig.3. Locating worldwide nanobiosensor research over a base map of science 
(Database: SCI) 
 
Exploring R&D to Application Connections 
A general “cross-chart” from fundamental nanotechnology 
to market applications (Fig. 4) reveals vital links among 
nanomaterials, biosensors, and applications. It also explores 
the underlying functions of how nanomaterials can enhance 
biosensors, which can help future innovation path mapping.   
From Fig. 4, we seek to find how nanotechnologies and 
nanomaterials can enhance biosensor capabilities.  
Nanomaterials can contribute to either the bio recognition 
element or the transducer of a biosensor (or both).  The 
functions of nanomaterials used in bio recognition can be 
divided into two classes.  The first class is referred to as 
“target labelling” using “0D” (zero-dimensional) or “1D” 
(one-dimensional) nanomaterials (e.g., using semiconductor 
nanoparticles).  The second class of nanomaterial functions 
used in bio recognition elements is mainly in the form of 
replacing the traditional molecular recognition layers using 
various nanomaterials. 
In generating Fig. 4 we sought to localize nano-
enhancements – i.e., to see if certain nanostructures contribute 
to particular functions that might apply to only certain 
applications.  For instance, if use of the 3D nanostructures 
might only pertain to a limited subset of functions, which 
contribute mainly to only one or two types of biosensors, we 
could then key on the organizations focusing on those to 
explore likely innovation prospects.  Results do not localize 
neatly (Fig. 4).  On the other hand, note that the several nano 
material types are not equally associated with functional 
advantages apt to contribute to particular biosensors.  So, for 
instance, if we wanted to “zoom in” on one type of biosensor 
(say, thermal), Fig. 4 would orient us toward particular gains 
(e.g., patents pertaining to enhanced heat transfer or binding 
capacity).  The broad arrows between biosensors and 
application sectors reflect that we have not been able to 
restrict types of biosensors to certain sectors.  
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Fig.4. General nanobiosensor technology – application cross-chart [12] 
 
Exploring Commercialization of This Research 
To explore the nanobiosensor commercialization prospects, 
a list of top corporations around the world is shown in TABLE 
II (based on research publication, as indexed in SCI).  From 
this table, we can see the countries with active industry 
involvement include the USA, China, Germany, Japan, 
Canada, and Sweden.  Although the No. 1 company in the list 
is American, we conclude that industrial R&D on 
nanobiosensors is led by Japanese companies, with 5 
companies in the top 15.  We thus select Japan as our key 
focus for leading edge commercialization.   
 
TABLE II 
TOP 15 NANOBIOSNESOR CORPORATIONS IN THE WORLD (DATABASE: SCI) 
 
No. #Records Affiliation           Country 
1 13 Geocenters Inc USA 
2 11 Wuhan Iron & Steel Co China 
3 10 KFA Julich GmbH Germany 
4 8 Nanomix Inc USA 
5 6 BAS Co Ltd Japan 
6 6 Japan Sci & Technol Corp Japan 
7 5 FONA Technol Inc Canada 
8 5 Siemens AG Germany 
9 4 Biacore AB Sweden 
10 4 Ebiochip Syst GmbH Germany 
11 4 Eicom Ltd Japan 
12 4 NTT Adv Technol Japan 
13 3 Abgenix Inc USA 
14 3 Cent Res Labs Ltd England 
15 3 Hitachi Ltd Japan 
    The map in Fig. 5 explores co-authoring among top 
corporations and other top R&D organizations in Japan.  This 
can help us answer several important questions: Are there 
networks among key nanobiosensor research groups? How are 
the industry players networking with other R&D organizations? 
What are such networks emphasizing? Some observations: 
    (1) A relatively large number of Japanese corporations are 
publishing on nanobiosensor research; 
    (2) We observe notable cooperation between industry-
industry and industry-academic organizations within Japan; 
    (3) Academic organizations comprise the core of these 
research networks, connecting several corporations (as circled 
in red in Fig. 5); 
    (4) Key academic organizations which are engaged with 
industry include: Keio University, Kyushu University, 
University of Tokyo, Natl Inst Adv Ind Sci & Technol, Tokyo 
University of Technology, University of Tsukuba. 
Furthermore, we also investigate more deeply to find what 
these networks are doing through the text analysis of their co-
authored papers. 
    (1) Network around Keio University appears to focus on the 
enhancement of biosensor sensitivity via improving catalytic 
ability of nanoparticles in electrochemical sensing [17]; 
    (2) Network circled around Kyushu University seems to 
focus on the enhancement of biosensor sensitivity via using 
the magnetic field of magnetic nanoparticles [18]; 
    (3) Network circled around the University of Tokyo: focus 
on the enhancement of SPR biosensor sensitivity and stability 
via using thin film and SAM (a 2D nanostructure)[19]; 
    (4) Network circled around the National Institute of 
Advanced Industrial Science & Technology: focus on the 
enhancement of biosensor sensitivity via taking advantage of 
the biocompatibility of polymer nanoparticles in 
mass/piezoelectric sensing [20]. 
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Fig.5. Cooperation between companies and other organizations in Japanese nanobiosensor research (Database: SCI) 
 
    
    In addition, we match the top 10 Corporations in Japan with 
the Subject Categories most associated with their research 
publication (Fig. 6).    
Results suggest that the Japanese nanobiosensor companies 
are heavily involved with Analytical Chemistry.  This 
concentration contrasts with the pattern seen for US 
companies publishing on nanobiosensors (not shown); their 
topical emphases vary more widely. 
 
Forecasting Likely Nanobiosensor Innovations 
Based on the case investigations presented, we identify 
some key factors affecting the development of nanobiosensors 
(TABLE III).   Notable Supports include: the heavy R&D 
funding, wide involvement of highly multidisciplinary 
research groups, strong research cooperation between   Fig.6. Co-occurrence matrix of corporations and Subject Categories 
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academic and corporate R&D groups, and the presence of 
potential users. Here, we have mainly analyzed fundamental 
nanobiosensor research; we are just pursuing “next steps” to 
profile patents and business publications that will speak to 
upcoming commercialization prospects.   
 
TABLE III 
CONTEXTUAL FORCES & FACTORS ANAYLYSES 
 
 Supports Barriers 
Governments • Strong financial support 
• High regulatory barriers 
(especially where FDA 
approval is needed) 
R&D groups 







• Generally still distant from 
commercialization 
• Ignorance of good 
integration of biosensors 
into easy-to-use systems 
Manufacturers 
• Promising market 
prospects 
• Ever-growing number 
of companies offering 
nanomaterials 
• Separate market segments 
• High standards of door-step 
to markets 
• High cost for needed 
performance 
• Scaling up manufacture of 
nanomaterials 
Users • Plenty of potential uses 
• High needs beyond present 
ability 
(Tiny, disposal, low-cost, fast, 
super-sensitive, non-invasive) 
 
    Like most emerging NES&Ts, nanobiosensors also face 
many challenges.  For example, the higher regulatory barriers 
and funding requirements for medical applications are notable.  
So, any small enterprises pursuing such innovations would 
confront major concerns about sufficient capitalization.  
Moreover, the cost of producing nanobiosensors is still a big 
problem at present.  It is still hard for nanobiosensors to 
achieve high performance with low cost. 
According to our framework (Fig. 1), the next step should 
be devoted to lay out alternative innovation pathways for 
further analyses.  We needed to gather professional opinions 
from researchers with backgrounds in biosensors, 
nanotechnologies, and, hopefully, nanobiosensors.   We first 
identified local technical experts, based on bibliometrics and 
collegial contacts.   E-mail questions provided an initial step 
to enlist cooperation.  One-on-one meetings proved very 
valuable to orient ourselves and the experts, and to decide how 
best to proceed.  Co-authoring of papers has been a useful way 
to help develop close cooperation with technical experts.   
We intend to pursue multi-path mapping analyses for 
nanobiosensors.  If time and resources were to allow, an 
interactive workshop with a spectrum of relevant experts 





The aim of this paper is to explore a framework to help 
characterize the new and emerging science & technology at its 
early stage.  The resulting approach can then serve to inform 
strategic technology planning and management. 
With the nanobiosensors case study, we see advantages of 
using this framework for NES&T Future-oriented Technology 
Analyses (FTA).   Setting forth the four stages seems vital to 
gain perspective on what is entailed in possible technological 
innovation here.  In the past, we may have been too ready to 
delve into detailed analyses of R&D activity without being 
clear on the broader system involved.  It is also useful to set 
forth the questions to be answered by the FTA effort ahead of 
data gathering and analyses.  In practice, iteration is useful.  
That is, investigation of R&D and contextual data can suggest 
refinements to the innovation indicators and management of 
technology (MOT) questions. 
Technology development stage analyses and TDS modeling 
complement each other to help understand the developmental 
situation for the target NES&T.  Simple “boxes and arrows” 
TDS modeling helps identify the key actors likely to pursue 
biosensor innovations based on nanomaterials.  
We adapt tech mining tools to help identify key R&D 
players and to study their interactions (research networks).   
“Mining” the R&D abstract records proved a fruitful source of 
ideas on possible nanobiosensor functions and applications.  
However, engaging technical experts was essential to establish 
valid sets of these, and important links, in the cross-charting 
activity. 
Our framework to analyze NES&Ts is a work in progress.  
As this and other case analyses show, NES&Ts can take on a 
variety of types.  The relative importance of particular 
technology management issues and questions should vary 
greatly.   MOT questions and the pertinent innovation 
indicators seem specific to each FTA.  In the present case 
illustration, we have mainly used only a limited spectrum of 
R&D information, with a special focus on linkages pointing 
toward potential commercialization.  We recognize the need to 
extend to patent and richer contextual information resources to 
round out these analyses.  That represents considerable work. 
We will continue to develop this approach to forecasting 
likely innovation pathways for NES&Ts.  With support to 
explore nano prospects, that constitutes our focal domain, but 
we recognize the need to test the approach on other new and 
emerging technologies.  In particular, we point to variation in 
the extent of existing applications as a key factor in 
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